Evidence for the modulation of cardiovascular function exists in the context of pathological states, such as hypertension, atherosclerosis, and ischemia/reperfusion injury, for several of these batokines (FGF21, neuregulin 4, 12,13-diHOME, and BAT-derived microRNAs) [11]. This evidence concerns the gene FGF21 and atherosclerosis.